Company Filing History:
Years Active: 2005-2006
Title: The Innovative Contributions of Karen J. Ferrante
Introduction
Karen J. Ferrante is a prominent inventor based in East Greenwich, Rhode Island. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of abnormal cell growth. With a total of 2 patents, her work focuses on innovative methods to combat diseases such as cancer.
Latest Patents
Ferrante's latest patents include groundbreaking methods for treating abnormal cell growth. One patent describes a method of monotherapy for subjects suffering from abnormal cell growth expressing the epidermal growth factor receptor (EGFR). This method involves orally administering a therapeutically effective amount of a crystalline polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride. The second patent relates to a stable crystalline form of the same compound, designated as the B polymorph. This invention details its production in pure form and its pharmaceutical applications in treating hyperproliferative disorders.
Career Highlights
Karen J. Ferrante is currently associated with Osi Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating effective treatments that address critical health issues.
Collaborations
Throughout her career, Ferrante has collaborated with notable colleagues, including Timothy Norris and Jeffrey W. Raggon. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Karen J. Ferrante's contributions to the field of pharmaceuticals exemplify her dedication to innovation and improving patient outcomes. Her patents reflect her commitment to advancing medical science and providing effective treatments for serious health conditions.